PRXV vs. LABU

Last updated Jun 23, 2026

PRXV (Praxis Impact Large Cap Value ETF) and LABU (Direxion Daily S&P Biotech Bull 3x Shares) are both exchange-traded funds - PRXV is a Large Cap Value Equities fund actively managed by Praxis, while LABU is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (300%). PRXV is actively managed, while LABU is passively managed. At a 0.43 correlation, their price movements are largely independent. PRXV charges 0.36%/yr vs 1.12%/yr for LABU.

Performance

PRXV vs. LABU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Praxis Impact Large Cap Value ETF (PRXV) and Direxion Daily S&P Biotech Bull 3x Shares (LABU). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

PRXV

• 1D: 0.83%
• 1M: 3.80%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

LABU

• 1D: 11.19%
• 1M: 31.29%
• YTD: 44.31%
• 6M: 30.68%
• 1Y: 313.64%
• 3Y*: 22.45%
• 5Y*: -30.40%
• 10Y*: -7.38%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PRXV vs. LABU - Yearly Performance Comparison

	2026 (YTD)
PRXV Praxis Impact Large Cap Value ETF	6.85%
LABU Direxion Daily S&P Biotech Bull 3x Shares	9.10%

Correlation

The correlation between PRXV and LABU is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Apr 20, 2026	0.43

Return for Risk

PRXV vs. LABU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PRXV

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

LABU

LABU Risk / Return Rank: 90
LABU Sharpe Ratio Rank: 96
LABU Sortino Ratio Rank: 85
LABU Omega Ratio Rank: 76
LABU Calmar Ratio Rank: 97
LABU Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PRXV vs. LABU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Praxis Impact Large Cap Value ETF (PRXV) and Direxion Daily S&P Biotech Bull 3x Shares (LABU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PRXV	LABU	Difference
Sharpe ratio: Return per unit of total volatility	—	4.01	—
Sortino ratio: Return per unit of downside risk	—	3.61	—
Omega ratio: Gain probability vs. loss probability	—	1.43	—
Calmar ratio: Return relative to maximum drawdown	—	10.29	—
Martin ratio: Return relative to average drawdown	—	28.91	—

Drawdowns

PRXV vs. LABU - Drawdown Comparison

The maximum PRXV drawdown since its inception was -1.41%, smaller than the maximum LABU drawdown of -99.18%. Use the drawdown chart below to compare losses from any high point for PRXV and LABU.

Drawdown Indicators

	PRXV	LABU	Difference
Max Drawdown Largest peak-to-trough decline	-1.41%	-99.18%	+97.77%
Max Drawdown (1Y) Largest decline over 1 year	—	-30.70%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-78.30%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-97.59%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-98.96%	—
Current Drawdown Current decline from peak	0.00%	-94.92%	+94.92%
Average Drawdown Average peak-to-trough decline	-0.41%	-81.71%	+81.30%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	10.91%	—

Volatility

Volatility by Period

	PRXV	LABU	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	29.77%	—
Volatility (6M) Calculated over the trailing 6-month period	—	63.11%	—
Volatility (1Y) Calculated over the trailing 1-year period	10.71%	78.92%	-68.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	10.71%	95.94%	-85.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	10.71%	95.55%	-84.84%

PRXV vs. LABU - Expense Ratio Comparison

PRXV has a 0.36% expense ratio, which is lower than LABU's 1.12% expense ratio.

Dividends

PRXV vs. LABU - Dividend Comparison

PRXV has not paid dividends to shareholders, while LABU's dividend yield for the trailing twelve months is around 0.54%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
LABU Direxion Daily S&P Biotech Bull 3x Shares	0.54%	0.84%	0.35%	0.35%	0.00%	0.00%	0.00%	0.28%	0.64%	0.17%
PRXV Praxis Impact Large Cap Value ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both PRXV and LABU in my portfolio?

PRXV and LABU have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, PRXV or LABU?

On fees, PRXV is cheaper at 0.36% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, PRXV or LABU?

PRXV is cheaper with a 0.36% expense ratio, compared with 1.12% for LABU.

Which ETF pays a higher dividend yield, PRXV or LABU?

LABU has the higher dividend yield at 0.54%, compared with 0.00% for PRXV.

What is the main difference between PRXV and LABU?

PRXV is categorized as Large Cap Value Equities, while LABU is Leveraged Equities. They also come from different issuers: Praxis and Direxion. Their fees differ too: 0.36% for PRXV and 1.12% for LABU.